» Articles » PMID: 30271507

Testing a Combination of Markers of Systemic Redox Status As a Possible Tool for the Diagnosis of Late Onset Alzheimer's Disease

Overview
Journal Dis Markers
Publisher Wiley
Specialty Biochemistry
Date 2018 Oct 2
PMID 30271507
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Blood-based parameters reflecting systemic abnormalities associated with typical brain physiopathological hallmarks could be a satisfactory answer to the need of less costly/intrusive and widely available biomarkers for late onset Alzheimer's disease (LOAD). Cumulating evidence from ourselves and others suggests that systemic oxidative stress (OxS) is precociously associated with LOAD. On this basis, we aimed to identify a combination of markers of redox status that could aid the diagnosis of LOAD.

Methods: We reexamined and crossed previous data on 9 serum markers of OxS obtained in a cohort including = 84 controls and = 90 LOAD patients by multivariate logistic regression analyses.

Results: A multimarker panel was identified that included significantly increased (hydroperoxides and uric acid) and decreased (thiols, residual antioxidant power, and arylesterase activity) markers. The multivariate model yielded an area under receiver-operating characteristic curve (AUC) of 0.808 for the discrimination between controls and LOAD patients, with specificity and sensitivity of 64% and 79%, respectively.

Conclusions: This study identified a panel of serum markers that distinguish individuals with LOAD from cognitively healthy control subjects. Replication studies on a larger independent cohort are required to confirm and extend our data.

Citing Articles

Investigation of coenzyme Q10 status, serum amyloid-β, and tau protein in patients with dementia.

Chang P, Chou H, Lai T, Yen C, Pan J, Lin P Front Aging Neurosci. 2022; 14:910289.

PMID: 35959290 PMC: 9358012. DOI: 10.3389/fnagi.2022.910289.


The association of serum uric acid with cognitive impairment and ATN biomarkers.

Huang S, Wang J, Fan D, Luo T, Li Y, Tu Y Front Aging Neurosci. 2022; 14:943380.

PMID: 35923549 PMC: 9339963. DOI: 10.3389/fnagi.2022.943380.


The Influence of Serum Uric Acid Level on Alzheimer's Disease: A Narrative Review.

Qiao M, Chen C, Liang Y, Luo Y, Wu W Biomed Res Int. 2021; 2021:5525710.

PMID: 34124244 PMC: 8192189. DOI: 10.1155/2021/5525710.


Serum Uric Acid and the Risk of Dementia: A Systematic Review and Meta-Analysis.

Zhou Z, Zhong S, Liang Y, Zhang X, Zhang R, Kang K Front Aging Neurosci. 2021; 13:625690.

PMID: 33716713 PMC: 7947796. DOI: 10.3389/fnagi.2021.625690.


Responsive Expression of MafF to -Amyloid-Induced Oxidative Stress.

Wang X, Zhang Y, Wan X, Guo C, Cui J, Sun J Dis Markers. 2021; 2020:8861358.

PMID: 33488846 PMC: 7787795. DOI: 10.1155/2020/8861358.


References
1.
Ursini F, Maiorino M, Forman H . Redox homeostasis: The Golden Mean of healthy living. Redox Biol. 2016; 8:205-15. PMC: 4732014. DOI: 10.1016/j.redox.2016.01.010. View

2.
Rembach A, Stingo F, Peterson C, Vannucci M, Do K, Wilson W . Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's disease. J Alzheimers Dis. 2015; 44(3):917-25. PMC: 4499459. DOI: 10.3233/JAD-141497. View

3.
Castellazzi M, Trentini A, Romani A, Valacchi G, Bellini T, Bonaccorsi G . Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases. Int J Biochem Cell Biol. 2016; 81(Pt B):356-363. DOI: 10.1016/j.biocel.2016.06.008. View

4.
Hardy J . The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem. 2009; 110(4):1129-34. DOI: 10.1111/j.1471-4159.2009.06181.x. View

5.
Montine K, Quinn J, Zhang J, Fessel J, Roberts 2nd L, Morrow J . Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem Phys Lipids. 2004; 128(1-2):117-24. DOI: 10.1016/j.chemphyslip.2003.10.010. View